Immunitybio Inc (IBRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Sales | 41 | 360 | 73 | 118 | 35 |
| Gross Profit | 41 | 360 | 73 | 118 | 35 |
| Operating Expenses | 85,186 | 111,940 | 84,973 | 90,922 | 79,657 |
| Operating Income | -85,145 | -111,580 | -84,900 | -90,804 | -79,622 |
| Interest Expense | 32,235 | 29,816 | 28,562 | 16,764 | 9,698 |
| Other Income | -20,833 | 24,813 | 5,170 | -3,593 | -5,515 |
| Pre-tax Income | -138,213 | -116,583 | -108,292 | -111,161 | -94,835 |
| Net Income Continuous | -138,213 | -116,583 | -108,326 | -111,161 | -94,835 |
| Minority Interests | -334 | -240 | -111 | -223 | -247 |
| Net Income | $-137,879 | $-116,343 | $-108,215 | $-110,938 | $-94,588 |
| EPS Basic Total Ops | -0.32 | -0.27 | -0.26 | -0.28 | -0.24 |
| EPS Basic Continuous Ops | -0.32 | -0.27 | -0.27 | -0.28 | -0.24 |
| EPS Diluted Total Ops | -0.32 | -0.27 | -0.26 | -0.28 | -0.24 |
| EPS Diluted Continuous Ops | -0.32 | -0.27 | -0.27 | -0.28 | -0.24 |
| EBITDA(a) | $-68,175 | $-95,363 | $-68,634 | $-81,796 | $-73,496 |